Series A Round
Funding Details
Pelage Pharmaceuticals is a clinical-stage regenerative medicine biotech focused on developing innovative treatments for hair loss by activating hair follicle stem cells. The company aims to revolutionize the treatment of conditions such as androgenetic alopecia through its proprietary small molecule therapies. This funding round will support the advancement of their clinical programs and further development of their lead candidates.
Confidence Score
Participating Investors
Google, a subsidiary of Alphabet Inc., is a multinational technology company specializing in Internet-related services and products, including online ...
Main Street Advisors is a venture capital firm that specializes in early-stage investments in innovative healthcare companies.
Related Tweets
No tweets found for this funding round.